Dr. Saveen Semage re-appointed as CEO of NMRA

The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- Sri Lanka economy grew 5% in 2025: CBSL tells CoPF May 18, 2026
- Sri Lanka promotes 5,289 Tri Service personnel for War Heroes Day May 18, 2026
- Sri Lanka to criminalize tax violations under new IRD amendments May 18, 2026
- Sri Lanka announces fuel subsidy amid global oil crisis May 18, 2026
- Oil jumps as Trump warns Iran and Hormuz stays mostly shut May 18, 2026
